CVS Health Co. (NYSE:CVS) Receives $68.71 Average Target Price from Analysts

CVS Health Co. (NYSE:CVS) has been given an average recommendation of “Moderate Buy” by the nineteen research firms that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $68.71.

A number of research analysts have weighed in on the company. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Truist Financial dropped their price objective on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. UBS Group increased their price target on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Finally, Evercore ISI lifted their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th.

CVS Health Price Performance

Shares of NYSE:CVS opened at $53.87 on Friday. CVS Health has a one year low of $43.56 and a one year high of $80.75. The stock has a market cap of $67.79 billion, a PE ratio of 13.67, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. The business’s fifty day moving average price is $51.23 and its two-hundred day moving average price is $56.24. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 EPS. On average, analysts forecast that CVS Health will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.94%. CVS Health’s payout ratio is 67.51%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the third quarter worth $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the third quarter worth about $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the third quarter valued at approximately $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.